Cycle and Handa Signed an Exclusive Sales License Agreement Announcement Cycle Pharmaceuticals signed a us commercialization (sales) agreement with Handa Therapeutics LLC for PHYRAGO distribution (availability). The PHYRAGO is an FDA-approved drug for the treatment of the two types of leukemia, ...
Sarepta Therapeutics Pauses ELEVIDYS Shipments in the US to Play a Vital Role Announcement Sarepta Therapeutics, Inc., a known producer of precision genetic medicine for rare diseases, decided to temporarily and voluntarily halt all shipments in the United States for Elevidys (delandistrogene mo...
AstraZeneca Intends to Invest in America Announcement AstraZeneca plans to invest approximately $50 billion in the United States by around 2030 to manufacture medicines and boost its research and development efforts. The investment will unlock skilled indirect or direct jobs across the region th...
AusperBio Phase 3 Clinical Trial Approved by CDE Announcement Ausperbio Therapeutics Inc. and Ausper Biopharma Co., Ltd (merged Ausperbio), a biotechnology company known for the advancement in oligonucleotide therapies for chronic hepatitis B (CHB) functional cure, received approval to perform a...
NKGen Biotech and HekaBio Came Together to Bring New NK Cell Therapy to Japan Announcement NKGen Biotech, a US-headquartered clinical-stage biotechnology company with a strong focus on the development and commercialization of novel autologous and allogenic natural killer (NK) cell therapies, ann...
Korea’s CoresteamChemo & ATG Lifetech came Together to Expand the CRO’s Global Reach Partnership Overview A South Korea-based, leading GLP-certified preclinical CRO, CoresteamChemo, and a biotechnology company specialized in transcriptome analytics and organoid-based modeling, AT...
Rossari Biotech’s Q1 PAT Slides by 4% YoY to RS 34cr About Rossari Biotech Rossari Biotech is a specialty chemical manufacturer based in Mumbai, India, that provides intelligent and sustainable solutions for industrial consumers. Rossario Biotech operates manufacturing facilities, which ar...
SAPU Bioscience's Comprehensive Data Analysis Highlights Sapu Biosciences, LLC, a fully owned subsidiary of GMP Biotechnology Limited (GMP Bio), in partnership with Oncotelic Therapeutics, Inc., a biopharmaceutical company unlocking new stages of small molecule and RNA-targeted therapeutics for ...
Lisata and WARPNINE Cleared One Stage of their ILSTA trial in Australia Announcement The warpnine incorporated, Western Australia’s non-profit clinical research organization for rare, pancreatic, and gastrointestinal cancers, and Lisata Therapeutics Inc., a pharmaceutical company popular f...
10X Genomics and A*Star Genome Institute of Singapore Advance with a Breakthrough Announcement The 10x Genomics Inc., a captain of spatial biology and single-cell, and the A*STAR Genome Institute of Singapore have initiated a research collaboration, focusing on inference from integrated spatialo...
